Taysha Gene Therapies, Inc. (TSHA) Net margin 2022–2025
Taysha Gene Therapies, Inc. (TSHA) net profit margin by fiscal year — reported net income divided by reported revenue.
-1115.3%FY2025 · since FY2022: -6635.3% → -1115.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1115.3% | -43.6 pp |
| FY2024 | -1071.6% | -349.6 pp |
| FY2023 | -722.1% | +5913.2 pp |
| FY2022 | -6635.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice